Gene Mutation Linked to Childhood Blindness
A genetic mutation that contributes to sight loss in children has been identified by scientists. The mutation was identified in patients with a disease known as ocular coloboma, which causes part of the eye to be missing at birth.
The findings shed light on its causes and help to explain how genes contribute to development of the eye, researchers say.
Ocular coloboma accounts for up to 10 per cent of all childhood blindness. It can cause a distinctive keyhole-shaped pupil as it commonly results in a missing segment in the iris, the coloured part of the eye.
Few genetic causes have so far been found to explain the cause of coloboma.
"Sight loss in coloboma in children can be devastating. As this work progresses, we have the opportunity to come closer to understanding the causes."
George McNamara, Fight for Sight
The research team – lead by Dr Joe Rainger at the University of Edinburgh – worked with 12 families, studying the DNA of children with coloboma and their unaffected parents.
Using state-of-the-art genetic screening – known as whole exome sequencing – the scientists revealed mutations in 10 genes, three of which were linked to activity of one molecule.
The molecule – known as actin – is important to a number of vital cell functions, including maintenance of the cytoskeleton, which defines cell shape and structure.
Targeted gene sequencing was then carried out on a further 380 people with coloboma. This showed that one of the mutations – a specific alteration in the gene ACTG1 – recurred across a number of those tested.
The scientists edited this ACTG1 mutation into a line of mice using cutting-edge CRISPR/Cas9 gene-editing technology, and found that it had severe effects on the function of actin.
The newly-identified mutations are thought to affect how actin binds to other proteins and on actin stability, which could severely affect development of the eye in the womb, scientists say.
"Coloboma can have profound effects on visual ability, but it is very variable and therefore likely to be caused by a number of genes. Our work adds knowledge to our understanding of its onset as well as the importance of actin to eye development."
Dr Joe Rainger, The Roslin Institute
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.